Gene Symbol | Gene ID | Gene Info |
---|---|---|
HESX1
|
ENSG00000163666.4 | HESX homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr3_57230756_57231045 | HESX1 | 3066 | 0.241173 | 0.67 | 5.0e-02 | Click! |
chr3_57231282_57231557 | HESX1 | 2547 | 0.266857 | 0.64 | 6.1e-02 | Click! |
chr3_57231564_57231715 | HESX1 | 2327 | 0.282316 | 0.44 | 2.3e-01 | Click! |
chr3_57230583_57230734 | HESX1 | 3308 | 0.232692 | 0.44 | 2.4e-01 | Click! |
chr3_57260241_57260521 | HESX1 | 168 | 0.927401 | -0.13 | 7.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_16869822_16870309 | 0.64 |
BNC2 |
basonuclin 2 |
639 |
0.83 |
chr20_50384318_50384901 | 0.62 |
ATP9A |
ATPase, class II, type 9A |
258 |
0.94 |
chr4_57975609_57976167 | 0.61 |
IGFBP7-AS1 |
IGFBP7 antisense RNA 1 |
40 |
0.93 |
chr10_20106092_20106642 | 0.52 |
PLXDC2 |
plexin domain containing 2 |
1199 |
0.49 |
chr20_31062740_31063476 | 0.51 |
C20orf112 |
chromosome 20 open reading frame 112 |
8166 |
0.18 |
chr8_23711375_23711668 | 0.51 |
STC1 |
stanniocalcin 1 |
303 |
0.92 |
chrX_105969921_105970262 | 0.47 |
RNF128 |
ring finger protein 128, E3 ubiquitin protein ligase |
197 |
0.96 |
chr9_16726683_16727481 | 0.46 |
RP11-62F24.2 |
|
270 |
0.85 |
chr10_35102956_35103650 | 0.46 |
PARD3 |
par-3 family cell polarity regulator |
946 |
0.5 |
chr5_9544908_9545592 | 0.46 |
SEMA5A |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
937 |
0.56 |
chr11_126870507_126870686 | 0.46 |
KIRREL3 |
kin of IRRE like 3 (Drosophila) |
59 |
0.96 |
chr8_116463616_116464117 | 0.45 |
TRPS1 |
trichorhinophalangeal syndrome I |
40582 |
0.2 |
chr10_122216781_122217284 | 0.45 |
PPAPDC1A |
phosphatidic acid phosphatase type 2 domain containing 1A |
273 |
0.93 |
chr1_120173925_120174356 | 0.44 |
ZNF697 |
zinc finger protein 697 |
16256 |
0.17 |
chr3_25470006_25470271 | 0.44 |
RARB |
retinoic acid receptor, beta |
336 |
0.93 |
chr17_81041156_81041564 | 0.44 |
METRNL |
meteorin, glial cell differentiation regulator-like |
589 |
0.79 |
chr10_21798969_21799358 | 0.43 |
SKIDA1 |
SKI/DACH domain containing 1 |
7685 |
0.13 |
chr13_38443188_38443573 | 0.43 |
TRPC4 |
transient receptor potential cation channel, subfamily C, member 4 |
480 |
0.86 |
chr11_16023597_16024065 | 0.42 |
CTD-3096P4.1 |
|
20905 |
0.28 |
chr1_94703270_94703530 | 0.42 |
ARHGAP29 |
Rho GTPase activating protein 29 |
211 |
0.96 |
chr12_46760644_46760919 | 0.40 |
SLC38A2 |
solute carrier family 38, member 2 |
1691 |
0.42 |
chr21_31311288_31312406 | 0.40 |
GRIK1 |
glutamate receptor, ionotropic, kainate 1 |
3 |
0.99 |
chr19_17889339_17889635 | 0.39 |
FCHO1 |
FCH domain only 1 |
15975 |
0.11 |
chr10_20105417_20106037 | 0.39 |
PLXDC2 |
plexin domain containing 2 |
559 |
0.77 |
chr4_134069309_134069654 | 0.39 |
PCDH10 |
protocadherin 10 |
989 |
0.73 |
chr16_55542879_55544136 | 0.39 |
LPCAT2 |
lysophosphatidylcholine acyltransferase 2 |
597 |
0.77 |
chr10_49812568_49813319 | 0.38 |
ARHGAP22 |
Rho GTPase activating protein 22 |
54 |
0.98 |
chrX_132548696_132549413 | 0.38 |
GPC4 |
glypican 4 |
464 |
0.88 |
chr1_66258526_66259233 | 0.38 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
15 |
0.99 |
chr17_27045033_27045379 | 0.37 |
RAB34 |
RAB34, member RAS oncogene family |
5 |
0.89 |
chr3_131854540_131854927 | 0.36 |
CPNE4 |
copine IV |
96283 |
0.08 |
chr6_128828944_128829440 | 0.36 |
RP1-86D1.4 |
|
2922 |
0.22 |
chr4_157892760_157892940 | 0.36 |
PDGFC |
platelet derived growth factor C |
304 |
0.92 |
chr1_178063691_178064117 | 0.35 |
RASAL2 |
RAS protein activator like 2 |
628 |
0.84 |
chr5_71403752_71403990 | 0.35 |
MAP1B |
microtubule-associated protein 1B |
558 |
0.84 |
chr16_73081294_73081963 | 0.35 |
ZFHX3 |
zinc finger homeobox 3 |
646 |
0.76 |
chr20_23617810_23618640 | 0.35 |
CST3 |
cystatin C |
357 |
0.87 |
chr4_141677411_141678112 | 0.35 |
TBC1D9 |
TBC1 domain family, member 9 (with GRAM domain) |
487 |
0.81 |
chr2_85981284_85981596 | 0.35 |
ATOH8 |
atonal homolog 8 (Drosophila) |
423 |
0.8 |
chr19_1154555_1155129 | 0.35 |
SBNO2 |
strawberry notch homolog 2 (Drosophila) |
293 |
0.85 |
chr21_33893367_33893849 | 0.35 |
ENSG00000252045 |
. |
17001 |
0.16 |
chr12_105476938_105477089 | 0.35 |
ALDH1L2 |
aldehyde dehydrogenase 1 family, member L2 |
1328 |
0.39 |
chr7_27138540_27138742 | 0.34 |
HOTAIRM1 |
HOXA transcript antisense RNA, myeloid-specific 1 |
183 |
0.86 |
chr6_125684588_125685144 | 0.34 |
RP11-735G4.1 |
|
10604 |
0.27 |
chr5_151065179_151065606 | 0.34 |
SPARC |
secreted protein, acidic, cysteine-rich (osteonectin) |
601 |
0.67 |
chr5_127874204_127874722 | 0.34 |
FBN2 |
fibrillin 2 |
547 |
0.58 |
chr12_54367124_54367311 | 0.34 |
HOXC11 |
homeobox C11 |
305 |
0.69 |
chr5_172754207_172754714 | 0.34 |
STC2 |
stanniocalcin 2 |
596 |
0.75 |
chr4_187647302_187647732 | 0.33 |
FAT1 |
FAT atypical cadherin 1 |
359 |
0.93 |
chr5_131594297_131594770 | 0.33 |
PDLIM4 |
PDZ and LIM domain 4 |
1133 |
0.45 |
chr1_45140674_45140825 | 0.33 |
C1orf228 |
chromosome 1 open reading frame 228 |
322 |
0.62 |
chr16_401820_402085 | 0.33 |
AXIN1 |
axin 1 |
497 |
0.67 |
chr16_70780347_70780498 | 0.33 |
RP11-394B2.6 |
|
538 |
0.68 |
chr5_54516767_54517029 | 0.33 |
MCIDAS |
multiciliate differentiation and DNA synthesis associated cell cycle protein |
6245 |
0.13 |
chr8_77586350_77586717 | 0.33 |
ZFHX4 |
zinc finger homeobox 4 |
6921 |
0.24 |
chr11_15135960_15136328 | 0.33 |
INSC |
inscuteable homolog (Drosophila) |
340 |
0.92 |
chr7_12811096_12811403 | 0.33 |
ENSG00000199470 |
. |
70735 |
0.11 |
chr7_116312458_116312799 | 0.33 |
MET |
met proto-oncogene |
169 |
0.97 |
chr10_93389674_93389884 | 0.33 |
PPP1R3C |
protein phosphatase 1, regulatory subunit 3C |
3032 |
0.38 |
chr2_62638898_62639095 | 0.33 |
ENSG00000241625 |
. |
79317 |
0.09 |
chr2_227660848_227660999 | 0.33 |
IRS1 |
insulin receptor substrate 1 |
3552 |
0.25 |
chr11_63774609_63774760 | 0.33 |
OTUB1 |
OTU domain, ubiquitin aldehyde binding 1 |
20370 |
0.1 |
chr22_46482353_46482522 | 0.32 |
FLJ27365 |
hsa-mir-4763 |
554 |
0.6 |
chr6_146755730_146756219 | 0.32 |
ENSG00000222971 |
. |
94418 |
0.08 |
chr6_121762848_121763040 | 0.32 |
GJA1 |
gap junction protein, alpha 1, 43kDa |
6106 |
0.19 |
chr1_78956350_78956733 | 0.32 |
PTGFR |
prostaglandin F receptor (FP) |
216 |
0.96 |
chr1_214723918_214724069 | 0.32 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
573 |
0.84 |
chr13_93880393_93880808 | 0.32 |
GPC6 |
glypican 6 |
1505 |
0.58 |
chr22_46402821_46403014 | 0.32 |
WNT7B |
wingless-type MMTV integration site family, member 7B |
29908 |
0.1 |
chr9_126088906_126089175 | 0.31 |
CRB2 |
crumbs homolog 2 (Drosophila) |
29409 |
0.19 |
chr12_6493326_6493955 | 0.31 |
LTBR |
lymphotoxin beta receptor (TNFR superfamily, member 3) |
221 |
0.89 |
chr9_129884150_129884930 | 0.31 |
ANGPTL2 |
angiopoietin-like 2 |
373 |
0.9 |
chr19_7953457_7953661 | 0.31 |
LRRC8E |
leucine rich repeat containing 8 family, member E |
123 |
0.88 |
chr1_32169073_32169273 | 0.31 |
COL16A1 |
collagen, type XVI, alpha 1 |
595 |
0.68 |
chr15_54270683_54271135 | 0.31 |
UNC13C |
unc-13 homolog C (C. elegans) |
34192 |
0.24 |
chr1_1293449_1293856 | 0.31 |
MXRA8 |
matrix-remodelling associated 8 |
263 |
0.78 |
chr2_9347772_9348251 | 0.31 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
1117 |
0.65 |
chr1_221067632_221067991 | 0.31 |
HLX |
H2.0-like homeobox |
13227 |
0.2 |
chr1_82267993_82268232 | 0.31 |
LPHN2 |
latrophilin 2 |
2030 |
0.49 |
chr21_30674225_30674446 | 0.30 |
BACH1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
1212 |
0.49 |
chr15_63768789_63769109 | 0.30 |
USP3 |
ubiquitin specific peptidase 3 |
27844 |
0.2 |
chr20_10651904_10652220 | 0.30 |
RP11-103J8.1 |
|
1514 |
0.43 |
chr12_30949792_30950072 | 0.30 |
CAPRIN2 |
caprin family member 2 |
42047 |
0.19 |
chr17_15168005_15168252 | 0.30 |
PMP22 |
peripheral myelin protein 22 |
496 |
0.74 |
chr5_76254834_76254985 | 0.30 |
CRHBP |
corticotropin releasing hormone binding protein |
6035 |
0.19 |
chr9_130860823_130861938 | 0.29 |
SLC25A25 |
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25 |
544 |
0.57 |
chr11_109293842_109294216 | 0.29 |
C11orf87 |
chromosome 11 open reading frame 87 |
1183 |
0.65 |
chr7_27201576_27201920 | 0.29 |
HOXA9 |
homeobox A9 |
3397 |
0.07 |
chr11_111848035_111848630 | 0.29 |
DIXDC1 |
DIX domain containing 1 |
299 |
0.84 |
chr5_171380881_171381289 | 0.29 |
FBXW11 |
F-box and WD repeat domain containing 11 |
23675 |
0.23 |
chr5_169398359_169398694 | 0.29 |
FAM196B |
family with sequence similarity 196, member B |
9218 |
0.26 |
chr4_89978098_89978439 | 0.29 |
FAM13A |
family with sequence similarity 13, member A |
43 |
0.98 |
chr4_74809740_74810515 | 0.29 |
PF4 |
platelet factor 4 |
37714 |
0.11 |
chr11_65203008_65203266 | 0.29 |
ENSG00000245532 |
. |
8792 |
0.12 |
chr3_16006218_16006514 | 0.28 |
ENSG00000207815 |
. |
91088 |
0.08 |
chr17_13504273_13504480 | 0.28 |
HS3ST3A1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
868 |
0.71 |
chr13_38445031_38445182 | 0.28 |
TRPC4 |
transient receptor potential cation channel, subfamily C, member 4 |
544 |
0.83 |
chr3_15837342_15837579 | 0.28 |
ANKRD28 |
ankyrin repeat domain 28 |
568 |
0.79 |
chr6_72178498_72178870 | 0.28 |
ENSG00000207827 |
. |
65360 |
0.11 |
chr18_12253921_12254616 | 0.28 |
CIDEA |
cell death-inducing DFFA-like effector a |
50 |
0.98 |
chr14_89021348_89021679 | 0.28 |
PTPN21 |
protein tyrosine phosphatase, non-receptor type 21 |
436 |
0.78 |
chr11_57528799_57529076 | 0.28 |
CTNND1 |
catenin (cadherin-associated protein), delta 1 |
297 |
0.86 |
chr11_47663191_47664130 | 0.28 |
MTCH2 |
mitochondrial carrier 2 |
426 |
0.74 |
chr20_19956550_19956867 | 0.28 |
NAA20 |
N(alpha)-acetyltransferase 20, NatB catalytic subunit |
41052 |
0.15 |
chr19_7735107_7735328 | 0.28 |
RETN |
resistin |
1004 |
0.3 |
chr16_29126642_29126901 | 0.27 |
CTB-134H23.3 |
|
8005 |
0.16 |
chr20_9048816_9049419 | 0.27 |
PLCB4 |
phospholipase C, beta 4 |
293 |
0.9 |
chr2_176932269_176932561 | 0.27 |
EVX2 |
even-skipped homeobox 2 |
16226 |
0.1 |
chr10_101756725_101756967 | 0.27 |
DNMBP |
dynamin binding protein |
12830 |
0.18 |
chr6_169653019_169653284 | 0.27 |
THBS2 |
thrombospondin 2 |
905 |
0.7 |
chr22_50913109_50913431 | 0.27 |
SBF1 |
SET binding factor 1 |
101 |
0.92 |
chr8_25042452_25043634 | 0.27 |
DOCK5 |
dedicator of cytokinesis 5 |
663 |
0.75 |
chr15_41913046_41914152 | 0.27 |
MGA |
MGA, MAX dimerization protein |
135 |
0.96 |
chr7_27204317_27204592 | 0.27 |
HOXA9 |
homeobox A9 |
691 |
0.36 |
chr9_38068307_38068649 | 0.27 |
SHB |
Src homology 2 domain containing adaptor protein B |
730 |
0.76 |
chr1_150602792_150602943 | 0.26 |
ENSA |
endosulfine alpha |
795 |
0.5 |
chr6_138910192_138910343 | 0.26 |
NHSL1 |
NHS-like 1 |
16590 |
0.25 |
chr6_139691315_139691533 | 0.26 |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
3926 |
0.31 |
chr17_2658644_2658831 | 0.26 |
ENSG00000265566 |
. |
1611 |
0.28 |
chr22_36862847_36862998 | 0.26 |
TXN2 |
thioredoxin 2 |
14465 |
0.14 |
chr16_14280583_14281066 | 0.26 |
MKL2 |
MKL/myocardin-like 2 |
52 |
0.98 |
chr17_79369714_79370212 | 0.26 |
RP11-1055B8.6 |
Uncharacterized protein |
688 |
0.54 |
chr12_3034547_3034860 | 0.26 |
ENSG00000238689 |
. |
3428 |
0.16 |
chr5_31274350_31274565 | 0.26 |
RP11-152K4.2 |
|
6740 |
0.3 |
chr11_79685002_79685197 | 0.26 |
ENSG00000221551 |
. |
281676 |
0.01 |
chr6_84743877_84744134 | 0.26 |
MRAP2 |
melanocortin 2 receptor accessory protein 2 |
530 |
0.87 |
chr3_150088154_150088521 | 0.26 |
TSC22D2 |
TSC22 domain family, member 2 |
37785 |
0.2 |
chr8_121137253_121137925 | 0.25 |
COL14A1 |
collagen, type XIV, alpha 1 |
237 |
0.96 |
chr6_130029394_130029625 | 0.25 |
ARHGAP18 |
Rho GTPase activating protein 18 |
1861 |
0.44 |
chr2_160142648_160143167 | 0.25 |
WDSUB1 |
WD repeat, sterile alpha motif and U-box domain containing 1 |
156 |
0.97 |
chr4_85886471_85886934 | 0.25 |
WDFY3 |
WD repeat and FYVE domain containing 3 |
801 |
0.75 |
chrX_10126292_10126538 | 0.25 |
CLCN4 |
chloride channel, voltage-sensitive 4 |
73 |
0.98 |
chr5_38846105_38846894 | 0.25 |
OSMR |
oncostatin M receptor |
398 |
0.91 |
chrX_8699533_8700279 | 0.25 |
KAL1 |
Kallmann syndrome 1 sequence |
321 |
0.94 |
chr17_70536173_70536521 | 0.25 |
ENSG00000200783 |
. |
123944 |
0.06 |
chr16_86602293_86602507 | 0.25 |
RP11-463O9.5 |
|
1033 |
0.41 |
chr16_73809854_73810059 | 0.25 |
PSMD7 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 |
520717 |
0.0 |
chr22_30648782_30648933 | 0.25 |
LIF |
leukemia inhibitory factor |
6017 |
0.11 |
chr1_68024994_68025388 | 0.25 |
ENSG00000207504 |
. |
18381 |
0.23 |
chr14_91282031_91282256 | 0.24 |
TTC7B |
tetratricopeptide repeat domain 7B |
618 |
0.82 |
chr22_44222171_44222754 | 0.24 |
RP3-388M5.9 |
|
14089 |
0.16 |
chr6_27637129_27637689 | 0.24 |
ENSG00000238648 |
. |
38221 |
0.13 |
chr3_11179453_11179614 | 0.24 |
HRH1 |
histamine receptor H1 |
754 |
0.77 |
chr22_45899514_45899973 | 0.24 |
FBLN1 |
fibulin 1 |
817 |
0.67 |
chr19_38422631_38423016 | 0.24 |
SIPA1L3 |
signal-induced proliferation-associated 1 like 3 |
24955 |
0.15 |
chr1_47489778_47489953 | 0.24 |
CYP4X1 |
cytochrome P450, family 4, subfamily X, polypeptide 1 |
625 |
0.75 |
chr8_108508090_108508241 | 0.24 |
ANGPT1 |
angiopoietin 1 |
942 |
0.74 |
chr6_58148368_58148782 | 0.24 |
ENSG00000212017 |
. |
893645 |
0.0 |
chr14_105147135_105147427 | 0.24 |
ENSG00000265291 |
. |
3195 |
0.18 |
chr4_77752291_77752556 | 0.24 |
ENSG00000264124 |
. |
22694 |
0.17 |
chr9_132539190_132539368 | 0.24 |
PTGES |
prostaglandin E synthase |
23953 |
0.12 |
chr11_44331338_44331543 | 0.24 |
ALX4 |
ALX homeobox 4 |
276 |
0.95 |
chr14_101292536_101293492 | 0.24 |
AL117190.2 |
|
2523 |
0.08 |
chr18_11149170_11149978 | 0.24 |
PIEZO2 |
piezo-type mechanosensitive ion channel component 2 |
987 |
0.72 |
chr15_99092145_99092331 | 0.24 |
FAM169B |
family with sequence similarity 169, member B |
34627 |
0.21 |
chr11_119210307_119210719 | 0.24 |
C1QTNF5 |
C1q and tumor necrosis factor related protein 5 |
1080 |
0.28 |
chr16_4103676_4103973 | 0.24 |
RP11-462G12.4 |
|
21811 |
0.19 |
chr18_25757173_25757741 | 0.24 |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
47 |
0.99 |
chr18_57364455_57364606 | 0.24 |
CCBE1 |
collagen and calcium binding EGF domains 1 |
82 |
0.93 |
chr7_42275735_42276044 | 0.24 |
GLI3 |
GLI family zinc finger 3 |
723 |
0.82 |
chr16_69959384_69959663 | 0.24 |
WWP2 |
WW domain containing E3 ubiquitin protein ligase 2 |
630 |
0.67 |
chr2_232531310_232531749 | 0.24 |
ENSG00000239202 |
. |
20545 |
0.15 |
chr8_62625183_62625719 | 0.24 |
ASPH |
aspartate beta-hydroxylase |
1633 |
0.37 |
chr18_46460407_46461027 | 0.24 |
SMAD7 |
SMAD family member 7 |
14158 |
0.24 |
chr1_119530163_119530409 | 0.24 |
TBX15 |
T-box 15 |
142 |
0.97 |
chr6_6737313_6737878 | 0.24 |
LY86-AS1 |
LY86 antisense RNA 1 |
114591 |
0.06 |
chr5_72252365_72253035 | 0.24 |
FCHO2 |
FCH domain only 2 |
802 |
0.7 |
chr2_205410516_205411018 | 0.24 |
PARD3B |
par-3 family cell polarity regulator beta |
44 |
0.99 |
chr15_72529055_72529849 | 0.23 |
PKM |
pyruvate kinase, muscle |
5288 |
0.17 |
chr18_7566824_7567068 | 0.23 |
PTPRM |
protein tyrosine phosphatase, receptor type, M |
166 |
0.97 |
chr6_88427153_88427304 | 0.23 |
ENSG00000238628 |
. |
3405 |
0.25 |
chr11_65666484_65666730 | 0.23 |
FOSL1 |
FOS-like antigen 1 |
1283 |
0.23 |
chr10_79397825_79398297 | 0.23 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
66 |
0.98 |
chr6_137310724_137311134 | 0.23 |
RP11-204P2.3 |
|
5378 |
0.23 |
chr3_123168721_123169253 | 0.23 |
ADCY5 |
adenylate cyclase 5 |
382 |
0.9 |
chr22_46472803_46473256 | 0.23 |
FLJ27365 |
hsa-mir-4763 |
3163 |
0.13 |
chr3_24719479_24719694 | 0.23 |
ENSG00000265028 |
. |
156660 |
0.04 |
chr2_232229806_232230059 | 0.23 |
ENSG00000263641 |
. |
2513 |
0.26 |
chr5_42423499_42423764 | 0.23 |
GHR |
growth hormone receptor |
248 |
0.96 |
chr16_19421704_19421876 | 0.23 |
TMC5 |
transmembrane channel-like 5 |
71 |
0.95 |
chr10_33620428_33620906 | 0.23 |
NRP1 |
neuropilin 1 |
2643 |
0.37 |
chr4_20255612_20255816 | 0.23 |
SLIT2 |
slit homolog 2 (Drosophila) |
275 |
0.96 |
chr12_54379595_54379934 | 0.23 |
RP11-834C11.12 |
|
135 |
0.72 |
chr1_8762815_8763230 | 0.23 |
RERE |
arginine-glutamic acid dipeptide (RE) repeats |
256 |
0.95 |
chr8_89969714_89969944 | 0.23 |
RP11-586K2.1 |
|
257309 |
0.02 |
chr10_119303143_119303333 | 0.23 |
EMX2 |
empty spiracles homeobox 2 |
729 |
0.61 |
chr7_158441504_158441705 | 0.23 |
NCAPG2 |
non-SMC condensin II complex, subunit G2 |
18326 |
0.19 |
chr12_94134432_94134611 | 0.23 |
RP11-887P2.5 |
|
2922 |
0.31 |
chr8_57358039_57358590 | 0.23 |
RP11-17A4.2 |
|
52 |
0.69 |
chr7_80928308_80928745 | 0.23 |
AC005008.2 |
Uncharacterized protein |
111420 |
0.08 |
chr16_73082076_73082698 | 0.23 |
ZFHX3 |
zinc finger homeobox 3 |
113 |
0.97 |
chr2_160654775_160654966 | 0.23 |
CD302 |
CD302 molecule |
117 |
0.98 |
chr17_40933524_40933675 | 0.23 |
WNK4 |
WNK lysine deficient protein kinase 4 |
903 |
0.35 |
chr14_85999097_85999705 | 0.23 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
2829 |
0.32 |
chr12_727829_727980 | 0.23 |
NINJ2 |
ninjurin 2 |
8320 |
0.15 |
chr15_40530958_40531718 | 0.23 |
PAK6 |
p21 protein (Cdc42/Rac)-activated kinase 6 |
46 |
0.96 |
chr2_168151014_168151527 | 0.23 |
XIRP2 |
xin actin-binding repeat containing 2 |
107477 |
0.08 |
chr7_149193458_149193685 | 0.23 |
ZNF746 |
zinc finger protein 746 |
1253 |
0.51 |
chr8_55294582_55295235 | 0.23 |
ENSG00000244107 |
. |
38120 |
0.17 |
chr10_100027009_100027207 | 0.23 |
LOXL4 |
lysyl oxidase-like 4 |
899 |
0.63 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.2 | 0.6 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 0.6 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.2 | 0.5 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.5 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.6 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.4 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.2 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.3 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.2 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.3 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.3 | GO:1903053 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 1.4 | GO:0036294 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
0.1 | 0.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.1 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.1 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.3 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.2 | GO:0060433 | bronchus development(GO:0060433) |
0.1 | 0.2 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.2 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.1 | 0.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.5 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.1 | GO:0021508 | floor plate formation(GO:0021508) |
0.1 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.5 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.2 | GO:0045986 | relaxation of smooth muscle(GO:0044557) negative regulation of smooth muscle contraction(GO:0045986) relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 0.2 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.1 | 0.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 0.2 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.1 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.1 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.3 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.1 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.3 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.3 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.1 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
0.1 | 0.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.2 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.1 | 1.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.2 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.2 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.3 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.1 | GO:0032682 | negative regulation of chemokine production(GO:0032682) negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 0.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.1 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.1 | 0.2 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.1 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.1 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.1 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.0 | GO:0003309 | type B pancreatic cell differentiation(GO:0003309) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.2 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.2 | GO:0045844 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.0 | 0.2 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.0 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.2 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.0 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.2 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.0 | 0.2 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.0 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.2 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.0 | 0.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.2 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.0 | 0.1 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) positive regulation of cardiocyte differentiation(GO:1905209) |
0.0 | 0.2 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.5 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
0.0 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.2 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.2 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.0 | 0.1 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0060405 | regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) |
0.0 | 0.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.2 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.0 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.1 | GO:0010800 | regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.0 | 0.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.1 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.0 | 0.2 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.8 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.1 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 0.2 | GO:0007549 | dosage compensation(GO:0007549) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:2000192 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.0 | 0.0 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.0 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.1 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.0 | GO:0061299 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0060039 | pericardium development(GO:0060039) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.1 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.0 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.0 | 0.3 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.0 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.1 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.3 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.3 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.0 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.3 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.0 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.0 | 0.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.1 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.1 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.0 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0032967 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.7 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.4 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.0 | GO:0035850 | epithelial cell differentiation involved in kidney development(GO:0035850) |
0.0 | 0.3 | GO:0051303 | chromosome localization(GO:0050000) establishment of chromosome localization(GO:0051303) |
0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.3 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.1 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.0 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.1 | GO:0070245 | positive regulation of T cell apoptotic process(GO:0070234) positive regulation of thymocyte apoptotic process(GO:0070245) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.0 | GO:0030540 | female genitalia development(GO:0030540) |
0.0 | 0.0 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.2 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.0 | 0.1 | GO:0055093 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.0 | 0.0 | GO:0010934 | macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.0 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.1 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.1 | GO:0070841 | inclusion body assembly(GO:0070841) aggresome assembly(GO:0070842) |
0.0 | 0.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.0 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.0 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.0 | 0.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.1 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.1 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.0 | 0.3 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.2 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.0 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.2 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.0 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.0 | 0.0 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.5 | GO:0070509 | calcium ion import(GO:0070509) |
0.0 | 0.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.2 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.4 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.0 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.0 | 0.1 | GO:1901978 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.0 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.0 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.0 | 0.0 | GO:0046475 | phosphatidylcholine catabolic process(GO:0034638) glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.1 | GO:0015853 | adenine transport(GO:0015853) |
0.0 | 0.1 | GO:2000258 | negative regulation of protein processing(GO:0010955) negative regulation of complement activation(GO:0045916) negative regulation of protein maturation(GO:1903318) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.1 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.0 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.1 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.1 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.1 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 0.1 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.3 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.0 | 0.0 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.0 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.2 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.0 | GO:0032373 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.0 | 0.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.0 | GO:0060592 | mammary gland formation(GO:0060592) |
0.0 | 0.0 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.0 | GO:0060996 | dendritic spine development(GO:0060996) |
0.0 | 0.1 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.1 | GO:0006693 | prostaglandin metabolic process(GO:0006693) |
0.0 | 0.0 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 0.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.0 | 0.0 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.0 | 0.1 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.0 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.0 | 0.0 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.0 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.0 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.0 | GO:0009251 | glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.0 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.0 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.0 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 1.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.0 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.0 | 0.0 | GO:0050932 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.0 | 0.0 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.4 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.0 | GO:0051208 | sequestering of calcium ion(GO:0051208) |
0.0 | 0.0 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.0 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.0 | GO:1904251 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.1 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.1 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.0 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.0 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.1 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.1 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.0 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.0 | 0.4 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.2 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.1 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.0 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.0 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.1 | GO:0001662 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
0.0 | 0.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.0 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.0 | GO:0036230 | granulocyte activation(GO:0036230) |
0.0 | 0.0 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.0 | 0.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.0 | 0.0 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.0 | 0.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.0 | GO:0045117 | azole transport(GO:0045117) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.2 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.4 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.4 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 0.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.2 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.0 | 1.0 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.0 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.3 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.6 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.5 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.2 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.0 | 1.5 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.0 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.1 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 4.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.4 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.4 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 2.2 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.4 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.6 | GO:0005901 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.8 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.0 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.0 | 0.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.0 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 1.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.2 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.8 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.0 | GO:0031527 | filopodium membrane(GO:0031527) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.7 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.3 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 0.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.5 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.3 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.1 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.2 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.7 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.7 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.2 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.0 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.2 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.3 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0000036 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.4 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 2.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.0 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.0 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 2.0 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.4 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.0 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.0 | 0.0 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.2 | GO:0005024 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.2 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.0 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 1.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.3 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.0 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 1.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.0 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.3 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.1 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.0 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.0 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.0 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 1.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.1 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 4.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 3.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.5 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 2.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 1.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 2.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.0 | REACTOME NEUROTRANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL | Genes involved in Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |